GlassScriptPhysician profile
Michael L Schwartz
NPI 1013915784
$24,244.41
in general payments reported to CMS, 2019-2025
22 companies · $662 in 2025
The $662 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,708 · 2020: $4,056 · 2021: $5,828 · 2022: $2,274 · 2023: $1,415 · 2024: $301 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,378.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $10,979.42 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Medtronic Vascular, INC. | $9,270.99 | 2019-2020 | |
| Boston Scientific Corporation | $1,796.35 | 2019-2025 | General - Vascular Intervention, General - Non-Vascular Intervention, Lux-Dx Insertable Cardiac Monitor |
| Cook Medical LLC | $579.11 | 2019-2024 | Zenith Spiral-Z |
| Cardiovascular Systems INC. | $321.51 | 2019 | |
| W. L. Gore & Associates, INC. | $285.12 | 2020-2023 | Gore Viabahn Endoprosthesis |
| Medtronic, INC. | $273.78 | 2021-2024 | Closurefast |
| Janssen Pharmaceuticals, INC | $145.13 | 2020-2023 | Xarelto |
| Philips North America LLC | $92.70 | 2020 | |
| Abbott Laboratories | $72.38 | 2019 | |
| Merz North America, INC. | $55.14 | 2019-2022 | |
| Arrow International, INC. | $52.64 | 2019 | |
| Penumbra, INC. | $48.64 | 2020 | |
| Allergan, INC. | $47.93 | 2019-2021 | |
| Inari Medical, INC. | $44.24 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $39.77 | 2020-2022 | |
| Angiodynamics, INC. | $37.06 | 2019-2021 | |
| Ethicon US, LLC | $30.74 | 2025 | Dermabond |
| Bard Peripheral Vascular, INC. | $21.77 | 2021-2024 | Fluency Endovascular Stent Graft |
| Heron Therapeutics, INC. | $21.75 | 2024 | Aponvie |
| Merck Sharp & Dohme LLC | $15.25 | 2023 | Bridion |
| Tactile Systems Technology INC | $12.99 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.